Smith Anglin Financial’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-29,050
| Closed | -$243K | – | 210 |
|
|
2025
Q1 | $243K | Buy |
29,050
+50
| +0.2% | +$419 | 0.03% | 177 |
|
|
2024
Q4 | $230K | Hold |
29,000
| – | – | 0.02% | 182 |
|
|
2024
Q3 | $241K | Hold |
29,000
| – | – | 0.02% | 172 |
|
|
2024
Q2 | $184K | Hold |
29,000
| – | – | 0.02% | 189 |
|
|
2024
Q1 | $176K | Hold |
29,000
| – | – | 0.02% | 191 |
|
|
2023
Q4 | $176K | Hold |
29,000
| – | – | 0.02% | 176 |
|
|
2023
Q3 | $122K | Hold |
29,000
| – | – | 0.01% | 170 |
|
|
2023
Q2 | $89.9K | Sell |
29,000
-1,300
| -4% | -$4.03K | 0.01% | 168 |
|
|
2023
Q1 | $42.1K | Buy |
+30,300
| New | +$42.1K | 0.01% | 165 |
|